RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Pediatric Cancer - Pipeline Review, H2 2011
Aug 2011 - 57 pages - $500
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy Market
Dec 2010 - 5 pages - $500
Pediatric Cancer - Pipeline Review, Q4 2010
Dec 2010 - 31 pages - $500
Supportive Care in Oncology Market Forecast
Nov 2009 - $15,200
Pediatric Cancer - Pipeline Review, Q2 2011
Apr 2011 - 59 pages - $500
Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agents
Mar 2008 - 100 pages - $3,800
Bone Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 43 pages - $1,000
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Light Sciences Oncology, Inc. - Product Pipeline Review - Q4 2010
Dec 2010 - 49 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Pediatric del
Therapeutic target
Oncology del
Bone cancer del

Browse By

Therapeutic target
Chondrosarcoma
Ewings Sarcoma
Osteosarcoma
Spindle sarcoma
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us